Osa Clinical Trials 2023

What are the top hospitals conducting osa research?

Sleep disorders can have a significant impact on our overall health and well-being, and obstructive sleep apnea (OSA) is no exception. Fortunately, there are top hospitals across the United States dedicated to advancing research and treatment options for this condition. In Rochester, Minnesota, the renowned Mayo Clinic leads the way with seven active clinical trials focused specifically on OSA. Although they may seem relatively new to studying this disorder, having recorded their first trial in 2012, their commitment to finding answers is unquestionable.

In Boston, two notable hospitals stand out for their contributions to OSA research. Dana-Farber Cancer Institute currently has six ongoing clinical trials dedicated solely to this sleep-related disorder. While they may not have conducted any previous OSA trials yet since joining the fight against it recently demonstrates their enthusiasm towards making progress in understanding and treating OSA effectively.

Brigham and Women's Hospital also plays an important role in advancing knowledge about OSA with five active clinical trials underway. With a history of 28 past studies dating back to 2005 when they initiated their first recorded trial into osa; these remarkable efforts highlight how long they've been committed towards finding sound solutions for patients struggling with such sleeping ailments.

Joining the ranks of leading institutions is Connecticut Children's Medical Center located in Hartford where researchers are actively investigating potential breakthroughs through five ongoing clinical trials focused exclusively on OSA which marks a fresh start as theirs just began venturing into comprehensive analysis from2021 onwards thereby showcasing commendable dedication even amidst unprecedented circumstances

Finally rounding off our list is Johns Hopkins All Children's Hospital based in Saint Petersburg which although hasn't conducted any prior trials yet presents itself arduously at present assessing certain aspects through its own set of five current osa tests proving that every innovative step taken provides immense hope for individuals grappling with difficulties associated while resting or breathing during slumber.

These hospitals collectively highlight an unwavering commitment within the medical community to better understand and alleviate the challenges faced by individuals with OSA. Through ongoing clinical trials, these institutions strive to improve the lives of countless patients affected by this sleep disorder, ultimately providing a brighter future for those seeking restful nights and improved quality of life.

Which are the best cities for osa clinical trials?

When it comes to OSA (obstructive sleep apnea) clinical trials, several cities in the United States are at the forefront of research and innovation. Boston, Massachusetts leads with 33 active trials focusing on treatments like Mavacamten, CPAP therapy, and Nivolumab. New york City follows closely behind with 26 ongoing studies examining interventions such as Mavacamten, CPAP therapy, and Dinutuximab. Additionally, Los Angeles and Chicago each have 22 active trials exploring therapies like Doxorubicin, CPAP therapy, and Nivolumab. Lastly, Miami offers 18 ongoing trials investigating treatments including CPAP therapy and novel drug regimens like Regimen B (VAC/VI/temsirolimus). These cities serve as hubs for cutting-edge research in OSA treatment options that aim to improve quality of life for those affected by this condition.

Which are the top treatments for osa being explored in clinical trials?

Clinical trials are actively exploring the top treatments for obstructive sleep apnea (OSA). Leading the charge is the home sleep apnea test, which is currently under investigation in two ongoing trials. This innovative approach to diagnosing OSA first appeared on the research scene in 2022 and has already garnered attention with its potential benefits. Another standout treatment being explored is continuous positive airway pressure (CPAP), a well-established therapy that has been studied extensively throughout the years. Currently involved in two active trials and boasting a total of 69 all-time OSA trials since its introduction in 2004, CPAP remains an important contender as researchers strive to improve outcomes for individuals living with this condition.

What are the most recent clinical trials for osa?

Recent clinical trials have provided new insights into the treatment of obstructive sleep apnea (OSA). One notable study focuses on the use of eszopiclone, a medication that has shown promise in improving OSA symptoms. Another trial examines PF-07038124, a potential therapeutic agent for OSA management. Additionally, researchers have explored health communication messages as an intervention to enhance patient outcomes in this condition. Part I SAR441566 Dose B and Arm 2 - Combination eribulin and pembrolizumab arm are also being investigated as potential treatments for OSA. These ongoing trials represent important steps forward in addressing and managing this common sleep disorder.

What osa clinical trials were recently completed?

Recent clinical trials have made strides in the field of obstructive sleep apnea (OSA) research. In November 2021, Apnimed concluded their trial on AD109, a potential treatment for this condition. Jazz Pharmaceuticals' trial investigating Solriamfetol 150 mg Oral Tablet reached completion in August 2021. Additionally, Apnimed also wrapped up their study on AD113 in July 2021. Lastly, Eisai Inc.'s trial exploring Lemborexant 10 mg was completed in December 2020. These advancements highlight ongoing efforts to find effective therapies for OSA and bring hope to individuals affected by this disorder.